NewslettersCancer Stem Cell News Uracil- and Pyridine-Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem Cells By lbeveridge - April 3, 2024 0 Seven HDACi, showing either hydroxamate or 2′-aminoanilide function, were tested in colorectal cancer and glioblastoma multiforme CSCs to determine their effects on cell proliferation, H3 acetylation levels and in-cell HDAC activity. [ChemMedChem] Abstract